admin

The reason for investing in Ocugen (NASDAQ:OCGN) stock hasn’t changed. Bulls expect the FDA to allow Ocugen to market Bharat Biotech’s Covaxin vaccine in the U.S., enabling Ocugen to generate massive sales and rapidly boost OCGN stock.   Source: shutterstock.com/PhotobyTawat The problems with this thesis, though, remain the same as they’ve ever been. Despite a great
0 Comments
We highlight the top performing small cap ETFs of 2018 and the reasons behind their outperformance. (PXSG, FYC, SLYG). PowerShares Russell 2000 Pure Growth Portfolio: https://www.zacks.com/funds/etf/PXSG/profile?cid=CS-YOUTUBE-FT-VID First Trust Small Cap Growth AlphaDEX Fund: https://www.zacks.com/funds/etf/FYC/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P 600 Small Cap Growth ETF: https://www.zacks.com/funds/etf/SLYG/profile?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on
0 Comments
SmileDirectClub (NASDAQ:SDC) is an oral care company founded in 2014. Headquartered in Nashville, the company operates in the North America, Europe and Asia Pacific regions. Its primary offering is a clear aligner therapy treatment, but it also sells a variety of oral care products, such as whitening kits and gels, toothbrushes, toothpastes and water flossers. SDC
0 Comments
Rivian Automotive, founded by Robert “R.J.” Scaringe, is coming up fast in the rearview mirror of high-profile electric carmaker Tesla Inc. (TSLA). Largely unknown outside of automotive circles, the privately-held maker of premium electric sport utility vehicles (SUVs) and pickup trucks has yet to sell a vehicle. The company confidentially filed for an initial public
0 Comments
Barry Silbert, Founder and CEO, Digital Currency Group  David A. Grogan | CNBC Digital Currency Group is selling shares to SoftBank and Google’s venture capital arm in a deal that values the crypto conglomerate at more than $10 billion.  The Manhattan-based, private company announced a secondary round on Monday, in which existing investors are selling
0 Comments
Former hedge fund manager Nelson Saeirs’ paintings visually represent the volatility trading algorithms he used on Wall Street. This one is titled, “The VIX over 40.” A reading in the VIX volatility index over 40 has historically preceded huge market losses Source: Nelson Saiers If there ever was a year active management should have outperformed
0 Comments
Given the potential, tremendous benefits of Cassava’s Alzheimer’s drug for millions of patients and the high probability of the drug being approved, I believe that Cassava Sciences (NASDAQ:SAVA) stock is vastly undervalued. Source: Pavel Kapysh / Shutterstock.com Additionally, my calculations indicate that the shares could easily soar over 200x after the company’s Alzheimer’s treatment, simufilam,
0 Comments
Early in October, I said that Cassava Sciences’ (NASDAQ:SAVA) big gains in late September had investors dreaming of a big payday for SAVA stock in 2022.  Source: Pavel Kapysh / Shutterstock.com I even suggested it might retest $100—a level it hit throughout the summer—by the end of 2021. I was convinced it would go on
0 Comments
Ahead of Intel’s (NASDAQ:INTC) recently posted third-quarter results, the stock rallied, in accordance with its tradition. INTC stock rose steadily from $52 to $56 ahead of its earnings, only to plunge and close below $50 after the results were released. Source: Kate Krav-Rude / Shutterstock.com Why did investors bet that Intel would beat analysts’ average
0 Comments